# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-110846
Filing Date
2025-11-13
Accepted
2025-11-13 07:30:54
Documents
55
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sgmt-20250930x10q.htm iXBRL | 10-Q | 1695924
2 | EX-31.1 | sgmt-20250930xex31d1.htm | EX-31.1 | 13071
3 | EX-31.2 | sgmt-20250930xex31d2.htm | EX-31.2 | 14039
4 | EX-32.1 | sgmt-20250930xex32d1.htm | EX-32.1 | 9776
| Complete submission text file | 0001104659-25-110846.txt |  | 6723313

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | sgmt-20250930.xsd | EX-101.SCH | 28043
6 | EX-101.CAL | sgmt-20250930_cal.xml | EX-101.CAL | 32516
7 | EX-101.DEF | sgmt-20250930_def.xml | EX-101.DEF | 169244
8 | EX-101.LAB | sgmt-20250930_lab.xml | EX-101.LAB | 336566
9 | EX-101.PRE | sgmt-20250930_pre.xml | EX-101.PRE | 254629
58 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmt-20250930x10q_htm.xml | XML | 1353294

Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41742 | Film No.: 251475411
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)